Skip to main content
. 2019 Nov 5;12:1178633719884951. doi: 10.1177/1178633719884951

Table 3.

Prevalence of multi-drug resistance and ESBL production in NFGNB against 8 antimicrobial categories.

Species R0 R1 R2 R3 R4 R5 R6 R7 R8 n (%)
MDR
n (%)
XDR
n (%)
PDR
ESBL (%)
P. aeruginosa (n = 61) 2 1 2 1 0 1 46 4 4 56 (91.8) 6 (9.8) 4 (6.6) 40 (51.3)
P. fluorescens (n = 4) 2 0 2 0 0 0 0 0 0 0 (0.0) 0 (0.0) 0 (0.0)
P. putida (n = 6) 0 0 0 0 2 3 1 0 0 6 (100) 1 (16.7) 0 (0.0) 1 (1.3)
P. luteola (n = 7) 2 1 1 2 0 1 0 0 0 3 (42.9) 0 (0.0) 0 (0.0) 1 (1.3)
A. baumannii (n = 28) 0 1 1 1 5 0 0 7 13 26 (92.9) 10 (35.7) 7 (25.0) 21 (44.7)
A. calcoaceticus (n = 9) 0 0 0 1 3 1 0 0 4 9 (100) 0 (0.0) 3 (33.3) 2 (4.3)
A. iwofii (n = 7) 0 2 0 3 1 0 1 0 0 5 (71.4) 1 (14.3) 0 (0.0) 1 (2.1)
A. ursingii (n = 3) 0 1 1 1 0 0 0 0 0 1 (33.3) 0 (0.0) 0 (0.0)
C. pauculus (n = 1) 0 1 0 0 0 0 0 0 0 0 (0.0) 0 (0.0) 0 (0.0)
S. maltophiia (n = 1) 1 0 0 0 0 0 0 0 0 0 (0.0) 0 (0.0) 0 (0.0)
M. rhodesianum (n = 1) 0 0 0 1 0 0 0 0 0 1 (1000) 0 (0.0) 0 (0.0)
M. nonliquefaciens (n = 1) 0 0 0 0 1 0 0 0 0 1 (100) 0 (0.0) 0 (0.0)
S. paucimobilis (n = 4) 3 0 0 0 1 0 0 0 0 1 (25.0) 0 (0.0) 0 (0.0)
B. cepacia (n = 2) 0 0 O 0 1 0 0 0 1 1 (50.0) 0 (0.0) 0 (0.0)
Total 10 7 7 10 14 6 48 11 22 110 (81.5%) 18 (13.3%) 14 (10.4%)

Abbreviations: ESBL, extended spectrum beta lactamase; MDR, multi-drug resistant; NFGNB, Non-Fermenting Gram-Negative Bacilli; PDR, pandemic drug resistance; XDR, extensively drug resistance.

R0: no antibiotic resistant; R1: resistant to 1 antimicrobial category; R2: resistant to 2 antimicrobial categories; R3: resistant to 3 antimicrobial categories; R4: resistant to 4 antimicrobial categories; R5: resistant to 5 antimicrobial categories; R6: resistant to 6 antimicrobial categories, R7: resistant to 7 antimicrobial categories, R8: resistant to 8 antimicrobial categories.